GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Other Income (Expense)

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Other Income (Expense) : ¥-82 Mil (TTM As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Sichuan Goldstone Asia Pharmaceutical Other Income (Expense)?

Sichuan Goldstone Asia Pharmaceutical's other income expense for the Sichuan Goldstone Asia Pharmaceutical's pretax income for the three months ended in Mar. 2024 was ¥-2 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-82 Mil.

Sichuan Goldstone Asia Pharmaceutical Other Income (Expense) Historical Data

The historical data trend for Sichuan Goldstone Asia Pharmaceutical's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Goldstone Asia Pharmaceutical Other Income (Expense) Chart

Sichuan Goldstone Asia Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25.16 -675.01 -39.09 -4.30 -81.99

Sichuan Goldstone Asia Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.61 -4.47 -3.41 -71.51 -2.21

Sichuan Goldstone Asia Pharmaceutical Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-82 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sichuan Goldstone Asia Pharmaceutical  (SZSE:300434) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Distribution » Sichuan Goldstone Asia Pharmaceutical Inc (SZSE:300434) » Definitions » Other Income (Expense)
Comparable Companies
SZSE:000151 SHSE:600113 SHSE:600735 SHSE:600287 SHSE:600051 SHSE:600811 SHSE:601890 BJSE:836871 SHSE:600755 GWW FAST FERG WSO POOL ASX:REH XKRX:047050 WCC OSTO:INDT SITE TSX:TIH
Traded in Other Exchanges
N/A
Address
8 Jiayuan Road, 8th Floor, District A1, Dadi Xinguanghua Plaza, Chengdu, CHN, 610072
Website
http://www.goldstone-group.com
Sichuan Goldstone Asia Pharmaceutical Inc is engaged in development and application of steel-reinforced plastic composite pipe technology, providing customers with steel-reinforced plastic composite pipes from pipe structure, production process to construction technology. The company is also engaged in research and development, production and sales of medicines and health products.

Sichuan Goldstone Asia Pharmaceutical (SZSE:300434) Headlines

No Headlines